Thank you for joining Purple Innovation's fourth-quarter 2024 earnings call. A copy of our earnings press release is available on the Investor Relations section of Purple's website at www.Purple.com.

Completed successful clinical trials for CM24 and NT219 oncology assets, demonstrating clinical benefits and identifying potential biomarkersCM24 ...

We are thrilled to announce that The Purple Ostrich has been named Best Gifts Store in Westchester County in the 2024 Daily ...

As of December 31, 2024, Purple Biotech had cash and cash equivalents and short-term deposits of $8.2 million, providing the Company a cash runway into mid-2026. During the three months ended ...

Thank you for joining Purple Innovation's fourth-quarter 2024 earnings call. A copy of our earnings press release is available on the Investor Relations section of Purple's website at www.Purple.com.

Returned to Positive Adjusted EBITDA and Cash Flow in Fourth QuarterGAAP Gross Margin of 42.9% in Q4; Adjusted Gross Margin improved Over 810bps in Q4 Versus Last YearGenerated ...